These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 32647940)

  • 1. Evaluation of a beneficial effect of adjuvant chemotherapy in patients with stage I triple-negative breast cancer: a population-based study using the SEER 18 database.
    Du ZL; Wang Y; Wang DY; Zhang L; Bian ZM; Deng Y; Xu CS; Lin DC; Xie L; Jia Y; Gao JD; Zhang BL
    Breast Cancer Res Treat; 2020 Sep; 183(2):429-438. PubMed ID: 32647940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer.
    Zhai Z; Zheng Y; Yao J; Liu Y; Ruan J; Deng Y; Zhou L; Zhao P; Yang S; Hu J; We B; Wu Y; Zhang D; Kang H; Dai Z
    JAMA Netw Open; 2020 Nov; 3(11):e2021881. PubMed ID: 33211105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit of adjuvant chemotherapy in lymph node-negative, T1b and T1c triple-negative breast cancer.
    Carbajal-Ochoa W; Bravo-Solarte DC; Bernal AM; Anampa JD
    Breast Cancer Res Treat; 2024 Jan; 203(2):257-269. PubMed ID: 37833449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
    Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
    Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy after surgery has significant survival benefits for patients with triple-negative breast cancer.
    Yao Y; Chu Y; Xu B; Hu Q; Song Q
    Cancer Med; 2019 Feb; 8(2):554-563. PubMed ID: 30632300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are we overtreating stage I triple-negative breast cancer in Ontario? A population-based retrospective epidemiological analysis using the ICES database.
    Shum K; Hussein A; Hamm C
    Med Oncol; 2022 Sep; 39(12):228. PubMed ID: 36175693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCL2 is an independent predictor of outcome in basal-like triple-negative breast cancers treated with adjuvant anthracycline-based chemotherapy.
    Bouchalova K; Svoboda M; Kharaishvili G; Vrbkova J; Bouchal J; Trojanec R; Koudelakova V; Radova L; Cwiertka K; Hajduch M; Kolar Z
    Tumour Biol; 2015 Jun; 36(6):4243-52. PubMed ID: 25616695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis.
    He X; Ji J; Dong R; Liu H; Dai X; Wang C; Esteva FJ; Yeung SJ
    Breast Cancer Res Treat; 2019 Jan; 173(2):329-341. PubMed ID: 30341462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Survival Outcomes of T1aN0M0 Triple-Negative Breast Cancer With Adjuvant Chemotherapy.
    Fu WF; Chen QX; Wang XX; Zhang J; Song CG
    Front Oncol; 2020; 10():1753. PubMed ID: 33102205
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of response to neoadjuvant chemotherapy on surgical modality in patients with T1-2N0-1M0 triple-negative breast cancer.
    Chang L; Liu D; Hao Q; Ren X; Liu P; Liu X; Wei Y; Lin S; Ma X; Wu H; Kang H; Wang M
    J Cancer Res Clin Oncol; 2024 Aug; 150(8):378. PubMed ID: 39085623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.
    Chen HL; Zhou MQ; Tian W; Meng KX; He HF
    PLoS One; 2016; 11(10):e0165409. PubMed ID: 27798652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy in small node-negative triple-negative breast cancer.
    Steenbruggen TG; van Werkhoven E; van Ramshorst MS; Dezentjé VO; Kok M; Linn SC; Siesling S; Sonke GS
    Eur J Cancer; 2020 Aug; 135():66-74. PubMed ID: 32554215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T1-2N0M0 Triple-Negative Breast Cancer Treated With Breast-Conserving Therapy Has Better Survival Compared to Mastectomy: A SEER Population-Based Retrospective Analysis.
    Li H; Chen Y; Wang X; Tang L; Guan X
    Clin Breast Cancer; 2019 Dec; 19(6):e669-e682. PubMed ID: 31375327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER database.
    Shang Y; Wang X; Liu Y; Cheng W; Duan Y; Fang Z; Liu J; Kong F; Wang T; Yu T; Hu A; Zhang J; Zhang H; Li M; Rong Z; Li Y; Shakila SS; Li X; Feng J; Ma F; Guo B
    Breast Cancer; 2024 Jul; 31(4):684-694. PubMed ID: 38643430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy.
    Geurts VCM; Balduzzi S; Steenbruggen TG; Linn SC; Siesling S; Badve SS; DeMichele A; Ignatiadis M; Leon-Ferre RA; Goetz MP; Wolff AC; Klar N; Michiels S; Loi S; Adams S; Horlings HM; Sonke GS; Salgado R; Kok M
    JAMA Oncol; 2024 Aug; 10(8):1077-1086. PubMed ID: 38935352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local treatment for triple-negative breast cancer patients undergoing chemotherapy: breast-conserving surgery or total mastectomy?
    Guo L; Xie G; Wang R; Yang L; Sun L; Xu M; Yang W; Chung MC
    BMC Cancer; 2021 Jun; 21(1):717. PubMed ID: 34147061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis in triple-negative apocrine carcinomas of the breast: A population-based study.
    Wu W; Wu M; Peng G; Shi D; Zhang J
    Cancer Med; 2019 Dec; 8(18):7523-7531. PubMed ID: 31642210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of neoadjuvant chemotherapy for clinical T1 triple-negative breast cancer.
    Hao Q; Dai L; Chang L; Song D; Liu D; Ma X; Wu H; Kang H
    Sci Rep; 2024 Aug; 14(1):18055. PubMed ID: 39103475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Use and Impact of Chemotherapy in Lymph Node-Negative, T1a Triple-Negative Breast Cancer.
    Bravo-Solarte DC; Zhang F; Anampa JD
    Clin Breast Cancer; 2023 Oct; 23(7):763-773.e6. PubMed ID: 37648557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.
    Gu Y; Wu G; Zou X; Huang P; Yi L
    Med Sci Monit; 2020 Feb; 26():e920432. PubMed ID: 32043484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.